Lauppe, R. (2022) “Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration – a Swedish nationwide retrospective study”, Acta Oncologica, 61(11), pp. 1354–1361. doi: 10.1080/0284186X.2022.2133972.